MIR3188

Across TCGA pan-cancer cohorts, MIR3188 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated MIR3188 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR3188 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR3188 expression acts as an unfavorable survival marker, although some lineages such as MESO and STAD show a favorable association.

MESO, LUSC, and STAD are the cancer types where MIR3188 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	II,III,IV	0.312	0.160	.007	54	view →
LUSC	OS	Tertile	III,IV	0.298	0.712	<.001	33	view →
STAD	OS	Median	III,IV	0.489	0.265	.001	21	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
KIRC	DFS	Tertile	All	0.469	0.689	.005	12	view →
SKCM	DFS	Tertile	IV	0.040	0.620	.003	9	view →
CHOL	DFS	Tertile	II,III,IV	0.097	0.448	.013	9	view →
BLCA	OS	Tertile	IV	0.252	0.594	.021	9	view →
HNSC	DFS	Tertile	All	0.812	0.692	.016	9	view →
THYM	DFS	Tertile	II,III,IV	0.797	0.973	.003	7	view →
UCS	OS	Tertile	All	0.443	0.707	.040	6	view →
COAD	DFS	Tertile	III,IV	0.133	0.438	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

MIR3188–MESO (DFS)

Open the MESO breakdown →